Do Mergers Save Lives?
|Speaker:||Alice Bonaime, University of Arizona|
|Date: ||Tuesday 21 May 2019|
|Time: ||13:45 - 15:15|
|Location: ||Xfi Henderson Lecture Theatre|
Using novel data from the pharmaceutical industry, we study the impact of mergers on product
prices and innovation. Mergers are associated with increases in drug prices without expansions
in new drug output. Medications produced by acquiring rms increase in price approximately
5% more than medications sold by matched non-acquiring rms. Rival drug prices rise as well,
consistent with a spillover eect of mergers into the broader product market. Price increases are
most pronounced for deals associated with greater market power consolidation and within drugs
whose consumers are less price sensitive. Life-saving drugs are not exempt from prices hikes around
mergers; if anything, their prices increase more.